Approval · Notice of Compliance 26718 · 2021
COLD + SINUS: Notice of Compliance 26718
Issued September 24, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 26718
- Date
- September 24, 2021
- Company
- Vita Health Products Inc.Winnipeg, Manitoba, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- This SANDS is submitted for the review of additional private label brand mock-ups.
- Canadian reference product
- ADVIL COLD & SINUS (CAPLET)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| COLD + SINUS | 02352281 | Marketed |
Medicinal ingredients
- IBUPROFEN 200 MG per TAB
- PSEUDOEPHEDRINE HCL 30 MG per TAB